The risk of cancer correlates with age, which may be measured in various ways. The easiest measure—chronologic age—may not be the best. Instead, cancer risk may be better estimated by measuring biologic age, which is a matter of how well the body is working—or how well the body can be expected to work, given the state of the body’s DNA.
During normal aging, DNA accumulates methyl groups, epigenetic marks, at a rate that is faster or slower in different people. If the epigenetic clock runs fast, biologic age may exceed chronologic age, with implications for cancer risk.
How much might the risk of breast cancer be elevated when the epigenetic clock runs fast? To answer that question, scientists based at The National Institute of Environmental Health Sciences (NIEHS) measured baseline blood DNA methylation and looked for an association with the risk of developing breast cancer. The scientists, led by Jack A. Taylor, MD, PhD, senior investigator, NIEHS, determined that such an association does in fact exist.